STING1 and non-small cell lung carcinoma: In summary, our findings demonstrate that activation of the STING pathway in NSCLC is more prone to induce type III IFNs than type I IFNs, and thus we need to expand our focus on how different interferons may contribute to modulate the tumor microenvironment.